Shanghai Medicilon Inc (688202) — Cash Flow Reinvestment Rate

Latest as of June 2022: 17.76x

Shanghai Medicilon Inc (688202) has a Cash Flow Reinvestment Rate of 17.76x as of June 2022, reinvesting CN¥169.63 Million (capex CN¥34.63 Million plus investments CN¥135.00 Million) from operating cash flow of CN¥9.55 Million. Explore 688202 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

17.76x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥169.63 Million
Capex + Investments

Operating Cash Flow

CN¥9.55 Million
CNY

Capital Expenditures

CN¥34.63 Million
CNY

Shanghai Medicilon Inc Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Shanghai Medicilon Inc across 8 annual periods. Also explore Shanghai Medicilon Inc (688202) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Shanghai Medicilon Inc (2016–2025)

Year-by-year capital reinvestment analysis for Shanghai Medicilon Inc. For live market cap and broader valuation context, see Shanghai Medicilon Inc stock valuation.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2025 2.02x CN¥212.85 Million CN¥105.17 Million CN¥69.03 Million ▼ -94.5%
2023 36.89x CN¥1.23 Billion CN¥33.32 Million CN¥300.10 Million ▲ +4155.0%
2021 0.87x CN¥392.71 Million CN¥452.94 Million CN¥292.71 Million ▼ -5.0%
2020 0.91x CN¥189.61 Million CN¥207.77 Million CN¥118.72 Million ▼ -68.4%
2019 2.89x CN¥168.27 Million CN¥58.30 Million CN¥97.38 Million ▲ +51.7%
2018 1.90x CN¥135.26 Million CN¥71.11 Million CN¥64.37 Million ▲ +9.5%
2017 1.74x CN¥129.80 Million CN¥74.70 Million CN¥58.91 Million ▼ -16.1%
2016 2.07x CN¥70.70 Million CN¥34.13 Million CN¥39.31 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow